Peptidoglycan induced expression of peroxisome proliferator-activated receptor γ in mouse peritoneal macrophages: Role of ERK and JNK MAP kinases

Cytokine

Volumn 60, Issue 3, 2012, Pages 778-786

  Bhatt, Kunal H ^a   Sodhi, Ajit ^a   Chakraborty, Rituparna ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

ERK; JNK; NF B (p65); Peptidoglycan; PPAR expression

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDOGLYCAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFLAMMATORY DISEASE; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTHRACENES; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; NF-KAPPA B; PEPTIDOGLYCAN; PPAR GAMMA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867996020     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.07.036     Document Type: Article

References (49)

1. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
2. Hu E., Tontonoz P., Spiegelman B.M. Trans differentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci 1995, 92:9856-9860.
3. Akiyama T.E., Sakai S., Lambert G., et al. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 2002, 22:2607-2619.
4. Babaev V.R., Yancey P.G., Ryzhov S.V., et al. Conditional knockout of macrophage PPAR gamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscl Throm Vasc Biol 2005, 25:1647-1653.
5. Chawla A., Barak Y., Nagy L., et al. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 2001, 7:48-52.
6. Lee C.H., Evans R.M. Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis. Trends Endocrin Metab 2002, 13:331-335.
7. Moore K.J., Fitzgerald M.L., Freeman M.W. Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?. Curr Opin Lipidol 2001, 12:519-527.
8. Su C.G., Wen X., Bailey S.T., et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999, 104:383-389.
9. Desreumaux P., Dubuquoy L., Nutten S., et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J. Exp. Med. 2001, 193:827-838.
10. Saubermann L.J., Nakajima A., Wada K., et al. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm Bowel Dis 2002, 8:330-339.
11. Katayama K., Wada K., Nakajima A., et al. A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 2003, 124:1315-1324.
12. Lytle C., Tod T.J., Vo K.T., et al. The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm Bowel Dis 2005, 11:231-243.
13. Schaefer K.L., Denevich S., Ma C., et al. Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms. Inflamm Bowel Dis 2005, 11:244-252.
14. Nagy L., Tontonoz P., Alvarez J.G., et al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 1998, 93:229-240.
15. Tontonoz P., Nagy L., Alvarez J.G., et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93:241-252.
16. Li A.C., Brown K.K., Silvestre M.J., et al. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2000, 106:523-531.
17. Zhang L., Chawla A. Role of PPAR gamma in macrophage biology and atherosclerosis. Trends Endocrin Metab 2004, 15:500-505.
18. Hammad H., de Heer H.J., Soullie T., et al. Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. Am J Pathol 2004, 164:263-271.
19. Woerly G., Honda K., Loyens M., et al. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003, 198:411-421.
20. Trifilieff A., Bench A., Hanley M., et al. PPAR-alpha and -gamma but not-delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect. Brit J Pharmacol 2003, 139:163-171.
21. Demerjian M., Man M.Q., Choi E.H., et al. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model. Exp Dermatol 2006, 15:154-160.
22. Natarajan C., Bright J.J. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. Genes Immun 2002, 3:59-70.
23. Diab A., Deng C., Smith J.D., et al. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta (12, 14)-prostaglandin J (2) ameliorates experimental auto-immune encephalomyelitis. J Immunol 2002, 168:2508-2515.
24. Ricote M., Li A.C., Willson T.M., et al. The peroxisome proliferator activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
25. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86.
26. Welch J.S., Ricote M., Akiyama T.E., et al. PPAR gamma and PPAR delta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci 2003, 100:6712-6717.
27. Zhao W., Wang L., Zhang M., et al. Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter. J Biol Chem 2011, 286:5519-5528.
28. Appel S., Mirakaj V., Bringmann A., et al. PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways. Blood 2005, 106:3888-3894.
29. Crosby M.B., Svenson J.L., Zhang J., et al. Peroxisome proliferation-activated receptor (PPAR)-gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. J Pharmacol Exp Ther 2005, 312:69-76.
30. Shah Y.M., Morimura K., Gonzalez F.J. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis. Am J Physiol Gastrointest Liver Physiol 2007, 292:G657-G666.
31. Necela B.M., Su W., Thompson E.A. Toll-like receptor 4 mediates crosstalk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages. Immunology 2008, 125:344-358.
32. Bhatt K.H., Pandey R.K., Dahiya Y., et al. Protein kinase Cδ and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor-κB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro. Mol Immunol 2010, 47:861-870.
33. Wang Q., Dziarski R., Kirschning C.J., et al. Micrococci and peptidoglycan activate TLR2→MyD88→IRAK→TRAF→NIK→IKK→NF-κB signal transduction pathway that induces transcription of interleukin-8. Infect Immun 2001, 69:2270-2276.
34. Wang Z.M., Liu C., Dziarski R. Chemokines are the main pro-inflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J Biol Chem 2000, 275:20260-20267.
35. Mattsson E., Verhage L., Rollof J., et al. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-α, interleukin-1β and interleukin-6. FEMS Immunol Med Microbiol 1993, 7:281-287.
36. Xu Z., Dziarski R., Wang Q., et al. Bacterial peptidoglycan-induced TNF-α transcription is mediated through the transcription factors Egr-1, Elk-1, and NF-κB. J Immunol 2001, 167:6975-6982.
37. Singh R.A.K., Sodhi A. Antigen presentation by cisplatin-activated macrophages: role of soluble factor(s) and second messengers. Immunol Cell Biol 1998, 6:401-409.
38. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
39. Bhatt K.H., Sodhi A., Chakraborty R. Role of mitogen-activated protein kinases in peptidoglycan-induced expression of inducible nitric oxide synthase and nitric oxide in mouse peritoneal macrophages: extracellular signal-related kinase, a negative regulator. Clin Vaccine Immunol 2011, 18:994-1001.
40. Majai G., Sarang Z., Csomós K., et al. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur J Immunol 2007, 37(5):1343-1354.
41. Fu M., Zhang J., Lin Y., et al. Early stimulation and late inhibition of peroxisome proliferator-activated γ (PPARγ) gene expression by transforming growth factor-in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads. Biochem J 2003, 370:1019-1025.
42. Afif H., Benderdour M., Mfuna-Endam L., et al. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes. Arthritis Res Ther 2007, 9:R31.
43. Xu Z., Dziarski R., Wang Q., et al. Bacterial peptidoglycan-induced tnf-alpha transcription is mediated through the transcription factors Egr-1, Elk-1, and NF-kappaB. J Immunol 2001, 167(12):6975-6982.
44. Chung S.W., Kang B.Y., Kim S.H., et al. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB. J Biol Chem 2000, 275:32681-32687.
45. Kelly D., Campbell J.I., King T.P., et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004, 5:104-112.
46. Pu Z., Carrero J.A., Unanue E.R. Distinct recognition by two subsets of T cells of an MHC class II - peptide complex. Proc Natl Acad Sci USA 2002, 99:8844-8849.
47. Coste A., Dubourdeau M., Linas M.D., et al. PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. Immunity 2003, 19(3):329-339.
48. Ji J.D., Cheon H., Jun J.B., et al. Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes. J Autoimmun 2001, 17(3):215-221.
49. Chinetti G., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function. Curr Opin Lipidol 2003, 14:459-468.